IP Library › Assignment 036087/0950
Patent Assignment
Reel/Frame 036087/0950

Change of Name

Recorded: 2015-07-09 Pages: 5
Assignor
ENVIVO PHARMACEUTICALS, INC.
Executed: 2014-04-02
Assignee
FORUM PHARMACEUTICALS, INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property (1)
Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide Hydrochloride Monohydrate
Patent: 9,273,044 →
Application: 14/795,595 →
Publication: US 2016/0009707
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 9, 2015
From: OLIVER-SHAFFER, PATRICIA; SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 036049/0295 →
Assignment of Assignor's Interest Jul 9, 2015
From: KISHIDA, MUNEKI; ISHIGE, TAKAYUKI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 036049/0391 →
Assignment of Assignor's Interest Jul 9, 2015
From: MITSUBISHI TANABE PHARMA CORPORATION
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 036049/0466 →
Security Interest Jul 5, 2016
From: FORUM PHARMACEUTICALS INC.
To: FMR LLC
Reel/Frame 039254/0828 →